Moroz Maxim A, Zhang Hanwen, Lee Jason, Moroz Ekaterina, Zurita Juan, Shenker Larissa, Serganova Inna, Blasberg Ronald, Ponomarev Vladimir
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Crump Institute for Molecular Imaging, University of California, Los Angeles, California.
J Nucl Med. 2015 Jul;56(7):1055-60. doi: 10.2967/jnumed.115.159855. Epub 2015 May 29.
Monitoring genetically altered T cells is an important component of adoptive T cell therapy in patients, and the ability to visualize their trafficking/targeting, proliferation/expansion, and retention/death using highly sensitive reporter systems that do not induce an immunologic response would provide useful information. Therefore, we focused on human reporter gene systems that have the potential for translation to clinical studies. The objective of the in vivo imaging studies was to determine the minimum number of T cells that could be visualized with the different nuclear reporter systems. We determined the imaging sensitivity (lower limit of T cell detection) of each reporter using appropriate radiolabeled probes for PET or SPECT imaging.
Human T cells were transduced with retroviral vectors encoding for the human norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine kinase double mutant (hdCKDM), and herpes simplex virus type 1 thymidine kinase (hsvTK) reporter genes. After viability and growth were assessed, 10(5) to 3 × 10(6) reporter T cells were injected subcutaneously on the shoulder area. The corresponding radiolabeled probe was injected intravenously 30 min later, followed by sequential PET or SPECT imaging. Radioactivity at the T cell injection sites and in the thigh (background) was measured.
The viability and growth of experimental cells were unaffected by transduction. The hNET/meta-(18)F-fluorobenzylguanidine ((18)F-MFBG) reporter system could detect less than 1 × 10(5) T cells because of its high uptake in the transduced T cells and low background activity. The hNIS/(124)I-iodide reporter system could detect approximately 1 × 10(6) T cells; (124)I-iodide uptake at the T cell injection site was time-dependent and associated with high background. The hdCKDM/2'-(18)F-fluoro-5-ethyl-1-β-d-arabinofuranosyluracil ((18)F-FEAU) and hsvTK/(18)F-FEAU reporter systems detected approximately 3 × 10(5) T cells, respectively. (18)F-FEAU was a more efficient probe (higher uptake, lower background) than (124)I-1-(2-deoxy-2-fluoro-1-d-arabinofuranosyl)-5-iodouracil for both hdCKDM and hsvTK.
A comparison of different reporter gene-reporter probe systems for imaging of T cell number was performed, and the hNET/(18)F-MFBG PET reporter system was found to be the most sensitive and capable of detecting approximately 35-40 × 10(3) T cells at the site of T cell injection in the animal model.
监测基因改造的T细胞是患者过继性T细胞治疗的重要组成部分,使用不会引发免疫反应的高灵敏度报告系统来可视化其迁移/靶向、增殖/扩增以及留存/死亡情况,将能提供有用信息。因此,我们聚焦于具有转化为临床研究潜力的人类报告基因系统。体内成像研究的目的是确定不同核报告系统能够可视化的T细胞的最小数量。我们使用适用于PET或SPECT成像的放射性标记探针,确定了每个报告基因的成像灵敏度(T细胞检测下限)。
用编码人类去甲肾上腺素转运体(hNET)、人类钠碘同向转运体(hNIS)、人类脱氧胞苷激酶双突变体(hdCKDM)和单纯疱疹病毒1型胸苷激酶(hsvTK)报告基因的逆转录病毒载体转导人类T细胞。评估细胞活力和生长情况后,将10⁵至3×10⁶个报告基因T细胞皮下注射到肩部区域。30分钟后静脉注射相应的放射性标记探针,随后进行连续的PET或SPECT成像。测量T细胞注射部位和大腿(背景)的放射性。
转导未影响实验细胞的活力和生长。hNET/间位-(¹⁸)F-氟苄胍((¹⁸)F-MFBG)报告系统能够检测到少于1×10⁵个T细胞,因为其在转导的T细胞中摄取量高且背景活性低。hNIS/(¹²⁴)I-碘化物报告系统能够检测到约1×10⁶个T细胞;T细胞注射部位的(¹²⁴)I-碘化物摄取具有时间依赖性且背景较高。hdCKDM/2'-(¹⁸)F-氟-5-乙基-1-β-D-阿拉伯呋喃糖基尿嘧啶((¹⁸)F-FEAU)和hsvTK/(¹⁸)F-FEAU报告系统分别能够检测到约3×10⁵个T细胞。对于hdCKDM和hsvTK,(¹⁸)F-FEAU是比(¹²⁴)I-1-(2-脱氧-2-氟-1-D-阿拉伯呋喃糖基)-5-碘尿嘧啶更有效的探针(摄取量更高、背景更低)。
对用于T细胞数量成像的不同报告基因-报告探针系统进行了比较,发现hNET/(¹⁸)F-MFBG PET报告系统在动物模型的T细胞注射部位最为灵敏,能够检测到约35 - 40×10³个T细胞。